Literature DB >> 29556288

A new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomy.

Yukio Tokumitsu1, Kazuhiko Sakamoto1, Yoshihiro Tokuhisa1, Hiroto Matsui1, Satoshi Matsukuma1, Yoshinari Maeda2, Koichiro Sakata3, Hiroshi Wada4, Hidetoshi Eguchi4, Hiroyuki Ogihara5, Yusuke Fujita6, Yoshihiko Hamamoto6, Norio Iizuka7, Tomio Ueno8, Hiroaki Nagano1.   

Abstract

We previously reported the effectiveness of the product of tumor number and size (NxS factor) for the prognosis of hepatocellular carcinoma (HCC) in patients following hepatectomy. The present study aimed to propose a new score based on the NxS factor to predict HCC recurrence following hepatectomy. A total of 406 patients who underwent hepatectomy for HCC at Osaka University Graduate School of Medicine were retrospectively analyzed to develop the new score. Among clinicopathological factors, including the NxS factor, the marker subset that achieved the best performance for prediction of early recurrence was assessed, and a prognostic model for HCC recurrence after curative hepatectomy (REACH) was developed. As the validation set, 425 patients who underwent hepatectomy for HCC at Yamaguchi University Graduate School of Medicine and Shimonoseki Medical Center were analyzed, and the prognostic ability of the REACH score was compared with that of well-known staging systems. Following analysis, the REACH score was constructed using six covariates (NxS factor, microscopic hepatic vein invasion, differentiation, serum albumin, platelet count and indocyanine green retention rate at 15 min). In the validation set, the REACH score predicted early recurrence in 73 of 81 samples, with a sensitivity of 89% and a specificity of 58%. The area under the curve (AUC) of the receiver operating characteristic curve of the REACH score was 0.78 and 0.74, respectively, for 1- and 2-year recurrence after hepatectomy; each AUC was higher than that of any of the other staging systems. Survival analysis indicated the REACH score had the best predictive value in disease-free and overall survival. The present findings demonstrated that the REACH score may be used to classify patients with HCC into high- and low-risk of recurrence, and to predict subsequent survival following hepatic resection.

Entities:  

Keywords:  hepatectomy; hepatocellular carcinoma; prognostic score; recurrence

Year:  2018        PMID: 29556288      PMCID: PMC5844062          DOI: 10.3892/ol.2018.7821

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  44 in total

1.  Living donor liver transplantation for recurrent hepatocellular carcinoma after liver resection.

Authors:  Toshimi Kaido; Akira Mori; Yasuhiro Ogura; Koichiro Hata; Atsushi Yoshizawa; Taku Iida; Shintaro Yagi; Shinji Uemoto
Journal:  Surgery       Date:  2011-09-22       Impact factor: 3.982

2.  Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Authors:  Masatoshi Kudo; Hobyung Chung; Seiji Haji; Yukio Osaki; Hiroko Oka; Toshihito Seki; Hiroshi Kasugai; Yo Sasaki; Takashi Matsunaga
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

Review 3.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

4.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

5.  Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas.

Authors:  Osakuni Morimoto; Hiroaki Nagano; Masato Sakon; Yoshiyuki Fujiwara; Terumasa Yamada; Hidewaki Nakagawa; Atsushi Miyamoto; Motoi Kondo; Isao Arai; Tameyoshi Yamamoto; Hideo Ota; Keizo Dono; Koji Umeshita; Shoji Nakamori; Yo Sasaki; Osamu Ishikawa; Shingi Imaoka; Morito Monden
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

Review 6.  The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Authors:  Josep M Llovet; Josep Fuster; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

7.  Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma.

Authors:  K Ikeda; S Saitoh; A Tsubota; Y Arase; K Chayama; H Kumada; G Watanabe; M Tsurumaru
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

8.  Evaluation of liver function for hepatic resection for hepatocellular carcinoma in the liver with damaged parenchyma.

Authors:  Hisao Wakabayashi; Ken Ishimura; Kunihiko Izuishi; Yukihiko Karasawa; Hajime Maeta
Journal:  J Surg Res       Date:  2004-02       Impact factor: 2.192

9.  A morpho-molecular prognostic model for hepatocellular carcinoma.

Authors:  S Srivastava; K F Wong; C W Ong; C Y Huak; K G Yeoh; M Teh; J M Luk; M Salto-Tellez
Journal:  Br J Cancer       Date:  2012-06-19       Impact factor: 7.640

10.  Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.

Authors:  Honsoul Kim; Mi-Suk Park; Young Nyun Park; Hyunki Kim; Kyung Sik Kim; Jin Sub Choi; Sang Hoon Ahn; Kwang-Hyub Han; Myeong-Jin Kim; Ki Whang Kim
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

View more
  14 in total

1.  Major postoperative complications are associated with early recurrence of hepatocellular carcinoma following hepatectomy.

Authors:  Tatsunori Miyata; Takashi Matsumoto; Yosuke Nakao; Takaaki Higashi; Katsunori Imai; Hiromitsu Hayashi; Hidetoshi Nitta; Akira Chikamoto; Toru Beppu; Yo-Ichi Yamashita; Hideo Baba
Journal:  Langenbecks Arch Surg       Date:  2022-04-20       Impact factor: 2.895

2.  Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?

Authors:  Veeravich Jaruvongvanich; Tomoki Sempokuya; Linda Wong
Journal:  J Gastrointest Oncol       Date:  2018-08

3.  High Expression of SLC41A3 Correlates with Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Qian Li; Dan-Lei Xiong; Heng Wang; Wei-Li Jin; Ying-Yu Ma; Xiao-Ming Fan
Journal:  Onco Targets Ther       Date:  2021-05-05       Impact factor: 4.147

4.  FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis.

Authors:  Xiongfei Chen; Lishuang Ding; Deshuai Kong; Xiulei Zhao; Lili Liao; Yaomin Zhang; Fengshan Li; Ruhai Liu
Journal:  Open Life Sci       Date:  2020-04-20       Impact factor: 0.938

5.  Viral elimination is essential for improving surgical outcomes of hepatitis C virus-related hepatocellular carcinoma: Multicenter retrospective analysis.

Authors:  Masao Nakajima; Shogo Kobayashi; Hiroshi Wada; Akira Tomokuni; Hidenori Takahashi; Takehiro Noda; Hiroto Matsui; Satoshi Matsukuma; Shinsuke Kanekiyo; Yoshitaro Shindo; Yukio Tokumitsu; Yuki Nakagami; Nobuaki Suzuki; Shigeru Takeda; Masahiro Tanabe; Katsuyoshi Ito; Yoshinobu Hoshii; Hidetoshi Eguchi; Hiroaki Nagano
Journal:  Ann Gastroenterol Surg       Date:  2020-07-23

6.  Should we apply sorafenib in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy?

Authors:  Yun Huang; Zeyu Zhang; Yufan Zhou; Jiajin Yang; Kuan Hu; Zhiming Wang
Journal:  Onco Targets Ther       Date:  2019-01-11       Impact factor: 4.147

7.  Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.

Authors:  Wei Xu; Ruineng Li; Fei Liu
Journal:  Cancer Manag Res       Date:  2020-03-09       Impact factor: 3.989

8.  Expression of SLC17A9 in hepatocellular carcinoma and its clinical significance.

Authors:  Jingdong Wu; Yongfei Yang; Jiansheng Song
Journal:  Oncol Lett       Date:  2020-08-31       Impact factor: 2.967

9.  A model combining TNM stage and tumor size shows utility in predicting recurrence among patients with hepatocellular carcinoma after resection.

Authors:  Yu Zhang; Shu-Wei Chen; Li-Li Liu; Xia Yang; Shao-Hang Cai; Jing-Ping Yun
Journal:  Cancer Manag Res       Date:  2018-09-20       Impact factor: 3.989

10.  Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma.

Authors:  Jian Wang; Ao Huang; Yu-Peng Wang; Yue Yin; Pei-Yao Fu; Xin Zhang; Jian Zhou
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.